Bispecific Antibody Use After CAR-T Failure for B-Cell Lymphoma | Megan Melody, MD, MS | #ASH24

Read more about this topic in the article “If CAR T-Cell Therapy Fails, How Effective Are Bispecific Antibodies for Large B-Cell Lymphoma?”: https://healthtree.org/dlbcl/communit... Dr. Megan Melody from the Tampa General Hospital Cancer Institute discusses the use of bispecific antibodies for B-cell lymphoma patients that CAR-T therapy had previously failed for. Link to ASH playlist: https://healthtree.org/blood-cancer/u... ASH Abstract: Efficacy, Toxicity, and Predictors of Outcomes with CD3-CD20 Bi-Specific Antibodies Post CAR T-Cell Failure for Aggressive B-Cell Lymphoma #ASH24 #dlbcl #lymsm Follow HealthTree: https://linktr.ee/HealthTreeUniversity